Investigated event: Influence on protein activity
| Name | Value |
|---|---|
| Compound | MLS-2384 |
| Investigated event | Influence on protein activity |
| Experiment type | Western Blot |
| Concentration | 1.00 µM |
| Cell line | A2058 |
| Organism | Homo sapiens |
| Animal model | |
| STAT protein | |
| Other | p-ERK1/2 |
Reference
A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone. The New England journal of medicine S A Rosenberg, M T Lotze, L M Muul, A E Chang, F P Avis, S Leitman, W M Linehan, C N Robertson, R E Lee, J T Rubin, 316, 15, 1987-04-09, None, 10.4161/cbt.21781
DOI: 10.4161/cbt.21781
PUBMED: 3493432
PMCID: 22895078